Barriers to non-small cell lung cancer trial eligibility
Introduction: Cancer clinical trial (CCT) enrollment is low potentially threatening the generalizability of trial results and expedited regulatory approvals. We assessed whether type of initial patient appointment for non-small cell lung cancer (NSCLC) is associated with CCT eligibility. Methods: Us...
Main Authors: | Jeffrey J. Hardesty, Norma F. Kanarek |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865417301187 |
Similar Items
-
The effect of prior cancer on non‐small cell lung cancer trial eligibility
by: Michael Herman, et al.
Published: (2021-07-01) -
Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
by: Muneer J. Al-Husseini, et al.
Published: (2019-08-01) -
Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors
by: Abtahi, S., et al.
Published: (2022) -
Eligibility of real-world patients with metastatic breast cancer for clinical trials
by: Atul Batra, et al.
Published: (2020-12-01) -
Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible
by: Brian L. Egleston, et al.
Published: (2018-03-01)